ABVC BioPharma, Inc. (ABVC) stock
Close on Nov 12, 2026Market cap $25.59MP/E –Yield –
ABVC BioPharma statistics
66 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.96
- 2.22
Share statisticsIndustry
- Shares Change (YoY)
- 49.5%
- 10.8%
- Shares Change (QoQ)
- 4.17%
- 0.50%
- Float
- 27M
- 49M
- Shares Held by Insiders
- 0.49%
- 11.7%
- Shares Held by Institutions
- 4.09%
- 56.4%
Short sellingIndustry
- Short Interest
- 602,938
- –
- Short Interest Change
- 2.22%
- -0.80%
- Days to Cover
- 19.90
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $3.06
- –
- 52-Week Low
- $0.71
- –
- 20-Day Moving Average
- $1.00
- –
- 50-Day Moving Average
- $1.02
- –
- 200-Day Moving Average
- $1.21
- –
- Average True Range (14)
- $0.07
- –
- Price Change (1 Week)
- -1.03%
- -1.15%
- Price Change (1 Month)
- -5.88%
- -4.87%
- Price Change (3 Months)
- 6.68%
- -21.0%
- Price Change (6 Months)
- -11.1%
- -20.6%
- Price Change (YTD)
- -54.9%
- -23.6%
- Price Change (1 Year)
- -66.8%
- -22.4%
- Price Change (3 Years)
- -14.3%
- -29.5%
- Price Change (5 Years)
- -97.1%
- -77.9%
- Price Change (10 Years)
- -99.7%
- -65.4%
- Average Volume (10 Days)
- 26,780
- –
- Average Volume (20 Days)
- 29,193
- –
- Average Volume (90 Days)
- 96,253
- –
- Relative Volume
- 0.45
- 0.70
- Relative Strength Index (14)
- 44.1
- 43.4
- Volatility (1 Year)
- 86.1%
- 80.1%
- Beta (5 Years)
- 1.07
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -31.2%
- -49.9%
- Return on Assets (ROA)
- -18.9%
- -40.6%
- Return on Invested Capital (ROIC)
- -35.7%
- -32.9%
- Return on Capital Employed (ROCE)
- -44.2%
- -37.9%
Financial positionIndustry
- Current Ratio
- 0.20
- 3.30
- Quick Ratio
- 0.01
- 2.39
- Debt / Equity
- 0.00
- 0.49
- Interest Coverage
- -34.49
- -6.35
GrowthIndustry
- Revenue Growth (3Y CAGR)
- -32.7%
- 2.25%
- Revenue Growth (5Y CAGR)
- -9.33%
- 6.41%
EfficiencyIndustry
- Profits Per Employee
- -$206.05K
- -$689.41K
- Employee Count
- 19
- 74
- WACC
- 10.5%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- -$6.91M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- $36.45K
- $17.76M
- Net Cash Per Share
- $0.00
- $0.80
- Equity (Book Value)
- $13.05M
- $53.89M
- Book Value Per Share
- $0.49
- $1.50
- Tangible Book Value
- $13.05M
- $27.13M
- Working Capital
- -$5.79M
- $79.99M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -15.3%
- -21.8%
Taxes and interestIndustry
- Interest Expense
- $167.90K
- $2.90M
Scores and fair valueIndustry
- Altman Z-Score
- -4.82
- 0.23
- Piotroski F-Score
- 5
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | ABVC | S&P 500 | Difference | ABVC per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -2.0% | -2.7% | +0.7 pts | ||
| 3 months | -0.0% | -1.7% | +1.7 pts | ||
| Year to date | -54.9% | +11.9% | −66.8 pts | ||
| 1 year | -67.9% | +12.0% | −79.9 pts | ||
| 3 years | -9.4% | +78.2% | −87.6 pts | -3.2% | +21.2% |
| 5 years | -97.1% | +73.2% | −170.3 pts | -50.8% | +11.6% |
| 10 years | -99.7% | +309.6% | −409.4 pts | -44.7% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
1M ABVC shares were sold short on Oct 30, 2026, up 2.2% from the previous report. At recent volumes it would take 19.9 days to buy them back. Over the last 20 sessions, 20.6% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 602,938 | +2.2% | 30,302 | 19.9 |
| Oct 15, 2026 | 589,852 | +20.3% | 85,190 | 6.9 |
| Sep 30, 2026 | 490,291 | -2.9% | 136,331 | 3.6 |
| Sep 15, 2026 | 504,862 | -3.8% | 133,335 | 3.8 |
| Aug 31, 2026 | 525,025 | +22.3% | 96,392 | 5.5 |
| Aug 14, 2026 | 429,447 | -2.8% | 122,056 | 3.5 |
| Jul 31, 2026 | 441,768 | -5.0% | 78,740 | 5.6 |
| Jul 15, 2026 | 465,232 | +26.9% | 252,428 | 1.8 |
| Jun 30, 2026 | 366,695 | -6.3% | 174,545 | 2.1 |
| Jun 15, 2026 | 391,213 | +51.1% | 110,365 | 3.5 |
| May 29, 2026 | 258,898 | -5.1% | 144,539 | 1.8 |
| May 15, 2026 | 272,679 | +5.8% | 78,418 | 3.5 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?